Clinical Trials Logo

Filter by:
NCT ID: NCT04830384 Completed - Clinical trials for Nicotine Dependence, Cigarettes

Evaluation of LLLT/Music for Smoking Cessation

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this research is to study the preliminary effectiveness of a light therapy and music device for at-home use to aid the seasoned cigarette smoker in his/her attempt to stop smoking. This device, called the FQS system, is a type of cold, or non-heat producing laser and tranquil music system that will emit light and music onto the ear surface, through commonly found music earphones, available in most electronic stores. The theory behind this treatment technique is that the light and music will stimulate the part of the brain responsible for producing chemicals that satisfy the desire for nicotine. If this is correct, then the user will replace the need for nicotine with the pleasant treatment experience of light and music therapy.

NCT ID: NCT04830306 Completed - Clinical trials for Cardiorespiratory Fitness

Step, Walk, Bike: Comparisons of Fitness Assessments

Start date: April 6, 2022
Phase: N/A
Study type: Interventional

To compare cardiorespiratory fitness parameters (oxygen consumption and respiratory ventilation) measured during two sub-maximal exercise tests (six minute step test, 6MST & six minute walk test, 6 MWT) with maximal exercise test (cardiopulmonary exercise test, CPET)

NCT ID: NCT04829773 Completed - Clinical trials for Fibrodysplasia Ossificans Progressiva

Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult Subjects

Start date: January 3, 2019
Phase: Phase 1
Study type: Interventional

Study to evaluate the effect of food and the effect of swallowing capsule whole versus sprinkling on apple sauce on the pharmacokinetics (PK)/bioavailability of palovarotene, and evaluate the effect of palovarotene on the PK of the CYP3A4 substrate midazolam.

NCT ID: NCT04829760 Completed - Parkinson Disease Clinical Trials

The Effect of Psyllium and Wheat Bran on Body Weight in People With Parkinson's Disease and Constipation Symptoms

NRO
Start date: May 13, 2021
Phase: N/A
Study type: Interventional

This is a 10-week randomized, controlled study to compare the safety and efficacy of two common fiber supplements, psyllium and wheat bran in terms of changes in body weight, nutrition status, and bowel function in patients with Parkinson's Disease who have constipation symptoms. After a 2-week run-in period, participants will be randomized to receive 10 grams daily of psyllium, coarse wheat bran, or maltodextrin (placebo) for 8 weeks. Nutritional and neurological evaluations will be conducted at the beginning and end of the 8-week intervention period.

NCT ID: NCT04829721 Completed - Clinical trials for Urinary Incontinence

Pelvic Floor Disorder Assessment of Knowledge and Symptoms: an Educational Model in Spanish-Speaking Women

PAKS
Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Pelvic floor health workshops have previously been shown to be effective in improving postpartum knowledge, performance of pelvic floor muscle exercises, and bowel-specific quality of life. Group learning through a class focused on behavioral modification and pelvic floor muscle exercises for women with urinary incontinence, has been shown to be an effective means to educate women about urinary incontinence management. The PAKS study hopes to demonstrate whether Spanish-speaking women that undergo an informative workshop on pelvic floor disorders via video in Spanish are more likely to raise their level of knowledge surrounding pelvic floor disorders and improve the pelvic floor symptoms.

NCT ID: NCT04829552 Completed - Covid19 Clinical Trials

Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units

Start date: March 10, 2020
Phase:
Study type: Observational

This is a multi-center, retrospective, study to determine if therapeutic dose anticoagulation (High dose group) improves inpatient mortality in severely ill patients with COVID-19 compared to prophylactic dose anticoagulation (Low dose group). The study involved 704 individuals who were admitted to Beaumont Health System (BHS) from March 10th to April 15th, 2020.

NCT ID: NCT04829461 Completed - Cystoscopy Clinical Trials

Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible Cystoscopy

Start date: April 27, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the use of the single-use Ambu® aScope™ 4 Cysto for removal of ureteral stents as compared to routine flexible reusable cystoscopes.

NCT ID: NCT04829435 Completed - Gout Clinical Trials

Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)

MAD
Start date: April 21, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this Phase I study is to evaluate the safety and tolerability of ALLN-346 in in normal healthy volunteers, in an ascending dose design. ALLN-346 is an (oral) enzyme that specifically degrades urate in the intestinal tract.

NCT ID: NCT04829344 Completed - Anesthesia, Local Clinical Trials

A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

Start date: March 30, 2021
Phase: Phase 3
Study type: Interventional

This is a Phase 3, randomized, placebo-controlled, double masked, parallel design study in healthy subjects performed in the US. It is designed to evaluate the safety and anesthetic efficacy of AG-920 Sterile Topical Ophthalmic Solution.

NCT ID: NCT04829227 Completed - Skin Laxity Clinical Trials

Safety and Efficacy of Sofwave Treatment to Lift Lax Skin

Start date: January 10, 2020
Phase: Phase 3
Study type: Interventional

Open-label, non-randomized 2 arms prospective, multi-center, self-controlled clinical study with masked evaluation.